Pharmaceutical Development of Innovative Russian Radiopharmaceuticals Based on Bispecific Nanoantibodies to Gitr and Ctla-4 for the Theranostics of Oncological Diseases. Maystrenko, D. Nanobiotechnology Reports, 18(4):650–657, 2023. Query date: 2024-02-01 14:42:56
doi  bibtex   
@Article{pop00006,
  author   = {D.N. Maystrenko},
  title    = {Pharmaceutical Development of Innovative Russian Radiopharmaceuticals Based on Bispecific Nanoantibodies to Gitr and Ctla-4 for the Theranostics of Oncological Diseases},
  doi      = {10.1134/S2635167623600165},
  issn     = {2635-1676},
  note     = {Query date: 2024-02-01 14:42:56},
  number   = {4},
  pages    = {650--657},
  volume   = {18},
  citation = {https://api.elsevier.com/content/abstract/scopus_id/85180548770},
  journal  = {Nanobiotechnology Reports},
  type     = {Article},
  year     = {2023},
}

Downloads: 0